No definition available.
Iridocyclitis in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
H7_IRIDOCYCLITISINOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
723 |
4. Check minimum number of eventsNone |
723 |
5. Include endpointsNone |
723 |
6. Filter based on genotype QC (FinnGen only) |
691 |
Control definitions (FinnGen only)
- Control exclude
- H7_SCLERACORNEA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Iridocyclitis in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Iridocyclitis
- Disorders of sclera, cornea, iris and ciliary body
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3920 | 2066 | 1843 |
| Only index persons | 3697 | 1955 | 1742 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.07 | 0.07 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 53.62 | 55.44 | 51.59 |
| Only index persons | 53.59 | 55.89 | 51.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 691 | 386 | 305 |
| Unadjusted period prevalence (%) | 0.14 | 0.14 | 0.14 |
| Median age at first event (years) | 56.58 | 55.52 | 57.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 723
- Matched controls
- 7230
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M45
ICD-10 Finland
Ankylosing spondylitis
82.2
307.7
223
39
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1612.9
307.7
343
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
15.8
301.7
342
388
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
36.8
280.0
183
66
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
252.3
227
*
L04AX03
ATC
methotrexate; systemic
13.6
246.0
289
337
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
33.4
242.0
162
62
S01AD03
ATC
aciclovir; ophthalmic
31.3
234.0
160
65
A07EC01
ATC
sulfasalazine; oral, rectal
13.8
223.7
248
263
S01BA04
ATC
prednisolone; ophthalmic
40.7
222.9
139
42
L04AB04
ATC
adalimumab; parenteral
34.8
215.3
141
50
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
+∞
212.2
193
*
H20.1
ICD-10 Finland
Chronic iridocyclitis
+∞
211.1
192
*
S01BA01
ATC
dexamethasone; ophthalmic
23.0
195.8
151
82
L01BA01
ATC
methotrexate; systemic
20.2
180.9
148
91
S01ED51
ATC
timolol, combinations; ophthalmic
11.0
157.1
194
233
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
78.0
154.2
83
12
S01FA04
ATC
cyclopentolate; ophthalmic
58.2
137.8
78
15
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
10.1
137.3
178
226
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
9.4
125.0
171
231
S01ED01
ATC
timolol; ophthalmic
17.1
121.9
106
72
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
120.2
112
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
48.3
112.2
66
15
L04AB01
ATC
etanercept; parenteral
29.2
111.8
76
29
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
+∞
105.9
99
*
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
30.4
95.8
64
23
L04AB06
ATC
golimumab; parenteral
46.6
94.5
56
13
H19.2*B02.3
ICD-10 Finland
Keratitis and keratoconjunctivitis (interstitial) in zoster
+∞
90.6
85
*
H26.2
ICD-10 Finland
Complicated cataract
32.0
89.9
59
20
J05AB11
ATC
valaciclovir; oral
5.1
84.1
227
592
L04AA13
ATC
[U] leflunomide
14.8
81.3
75
56
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.3
79.7
447
1994
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
833.4
77.8
75
*
J05AB01
ATC
aciclovir; systemic
4.3
76.8
287
956
H16.0
ICD-10 Finland
Corneal ulcer
16.6
74.2
64
42
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
+∞
73.2
69
*
L88
ICPC
Rheumatoid/seropositive arthritis
9.8
70.5
86
98
S01BA07
ATC
fluorometholone; ophthalmic
19.5
64.4
51
28
H02AB06
ATC
prednisolone; systemic
3.8
63.4
477
2463
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.0
62.7
236
775
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
24.6
61.3
44
19
S01EA03
ATC
apraclonidine; ophthalmic
27.8
61.2
42
16
D86.0
ICD-10 Finland
Sarcoidosis of lung
16.9
61.2
52
33
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
20.0
60.1
47
25
B02.3
ICD-10 Finland
Zoster ocular disease
213.8
57.9
59
*
S01EA05
ATC
brimonidine; ophthalmic
12.5
56.5
57
49
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
3.4
56.4
351
1579
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
11.6
54.6
58
54
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.8
53.7
141
350
S01EC01
ATC
acetazolamide; systemic
11.6
53.7
57
53
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
18.2
52.7
43
25
P01BA02
ATC
hydroxychloroquine; oral
5.1
52.6
124
281
Z96.1
ICD-10 Finland
Presence of intraocular lens
4.1
52.6
175
520
L04AX01
ATC
azathioprine; systemic
7.2
51.7
82
127
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
142.7
50.5
53
*
114
Kela drug reimbursment
Glaucoma
4.8
48.0
120
285
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
81.7
47.6
53
7
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
19.0
47.6
38
21
S01BC03
ATC
diclofenac; ophthalmic
11.9
47.1
49
44
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.4
47.0
134
353
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
45.5
329
1569
B02.9
ICD-10 Finland
Zoster without complication
5.1
43.9
100
219
H02AB07
ATC
prednisone; oral
3.7
43.6
167
542
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
17.5
42.1
35
21
H221, M084,
ICD-10 Finland
+∞
41.0
39
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
41.0
417
2347
H22.0
ICD-10 Finland
Iridocyclitis in infectious and parasitic diseases classified elsewhere
419.9
40.5
40
*
H30.2
ICD-10 Finland
Posterior cyclitis
148.4
40.2
42
*
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
+∞
38.9
37
*
L04AA01
ATC
[U] ciclosporin
14.7
38.4
35
25
H57.1
ICD-10 Finland
Ocular pain
6.8
38.2
62
98
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
102.9
36.1
39
*
S01FA02
ATC
scopolamine; ophthalmic
70.4
35.3
40
6
H16.9
ICD-10 Finland
Keratitis, unspecified
82.4
35.2
39
5
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.7
34.3
280
1380
H04.10
ICD-10 Finland
Dry eye syndrome
3.7
34.1
124
385
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
57.2
32.6
38
7
B00.5
ICD-10 Finland
Herpesviral ocular disease
91.9
32.0
35
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.3
31.0
87
224
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.5
30.9
82
202
S01EE01
ATC
latanoprost; ophthalmic
4.5
30.0
78
189
S01EC04
ATC
brinzolamide; ophthalmic
5.8
29.8
57
106
Z3229
NOMESCO Finland
Other healthcare associate professional
3.7
28.9
101
304
H221, M083,
ICD-10 Finland
+∞
28.3
27
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.9
27.8
88
247
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
281.0
26.9
27
*
M13.9
ICD-10 Finland
Arthritis, unspecified
3.8
26.8
90
263
H40.0
ICD-10 Finland
Glaucoma suspect
3.8
26.5
88
255
L04AB05
ATC
certolizumab pegol; parenteral
38.3
26.4
33
9
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.5
25.4
65
155
WZA10
NOMESCO Finland
Extensive medical or dental certificate
8.4
24.9
33
41
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
39.0
24.1
30
8
H20.8
ICD-10 Finland
Other iridocyclitis
+∞
24.1
23
*
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
9.7
23.7
28
30
S01EE04
ATC
travoprost; ophthalmic
8.1
23.6
32
41
ZXA10
NOMESCO Finland
Bilateral
2.6
23.5
171
777
H26.4
ICD-10 Finland
After-cataract
3.3
23.3
94
309
L04AA11
ATC
[U] etanercept
37.7
23.1
29
8
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.0
23.0
116
435
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
226.6
21.7
22
*
XCK10
NOMESCO Finland
Photography of fundus of eye
3.1
20.9
97
346
A02BC02
ATC
pantoprazole; systemic
2.2
20.9
513
3783
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
75.7
19.8
22
*
ZXE00
NOMESCO Finland
One hour or less
2.1
19.4
309
1921
H26.3
ICD-10 Finland
Drug-induced cataract
18.8
19.2
29
16
XCK00
NOMESCO Finland
Perimetry
3.7
19.1
64
186
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
71.8
18.8
21
*
L04AA17
ATC
[U] adalimumab
39.5
18.6
23
6
H20
ICD-10 Finland
Iridocyclitis
45.3
18.3
22
5
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
5.6
18.2
35
65
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
+∞
17.8
17
*
N03AX16
ATC
[U] pregabalin
2.2
17.8
194
1039
S01EE05
ATC
tafluprost; ophthalmic
4.5
17.6
44
103
K50.8
ICD-10 Finland
Other Crohn disease
7.0
17.5
27
40
CHC05
NOMESCO Finland
Iridotomy
8.0
17.5
24
31
H03.1*B02.3
ICD-10 Finland
Zoster blepharitis
32.3
17.1
22
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
17.1
234
1363
CG2S4
NOMESCO Finland
Photography of cornea
64.9
16.8
19
*
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
+∞
16.7
16
*
UJF32
NOMESCO Finland
Coloscopy
2.1
16.4
208
1175
M01AH01
ATC
celecoxib; oral
2.3
16.4
150
745
132
Kela drug reimbursment
Sarcoidosis
15.8
16.3
26
17
WX140
NOMESCO Finland
Parabulbar anesthesy
3.8
16.2
50
137
H25.1
ICD-10 Finland
Senile nuclear cataract
2.1
16.1
205
1159
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
16.0
94
380
H35.36
ICD-10 Finland
Macular cyst
34.2
15.8
20
6
B02.8
ICD-10 Finland
Zoster with other complications
17.7
15.7
24
14
4AA12, ,
NOMESCO Finland
27.0
15.7
21
8
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.6
15.6
37
83
ZX120
NOMESCO Finland
Intravenous
2.7
15.5
89
356
S01BC05
ATC
ketorolac; ophthalmic
4.0
15.4
44
114
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
15.4
91
369
S01EC03
ATC
dorzolamide; ophthalmic
13.4
15.3
26
20
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
4.8
15.1
34
73
L04AD01
ATC
ciclosporin; systemic
5.9
15.0
27
47
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.1
15.0
65
222
B02
ICD-10 Finland
Zoster [herpes zoster]
3.6
14.9
51
150
L04AC10
ATC
secukinumab; parenteral
21.6
14.7
21
10
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
14.6
14
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.0
14.5
26
45
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.1
14.3
40
102
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.6
14.1
47
136
S01FA06
ATC
tropicamide; ophthalmic
54.4
13.9
16
*
TCG10
NOMESCO Finland
Removal of sutures from cornea
54.4
13.9
16
*
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
76.6
13.6
15
*
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
16.6
13.5
21
13
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
142.6
13.5
14
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
5.7
13.4
25
45
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
5.7
13.4
25
45
N02AX02
ATC
tramadol; systemic, rectal
1.8
13.1
318
2196
M05BA04
ATC
alendronic acid; oral
2.7
12.9
74
295
R4110
NOMESCO Finland
Physiotherapy
1.9
12.9
214
1313
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.2
12.8
51
166
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
6.1
12.7
22
37
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
+∞
12.5
12
*
4AB02, ,
NOMESCO Finland
24.8
12.5
17
7
Z3226
NOMESCO Finland
Physiotherapist
2.0
12.4
148
808
XCH00
NOMESCO Finland
Eye pressure measurement
3.4
12.4
45
138
NF1AA
NOMESCO Finland
Hip X-ray examination
2.6
12.3
74
302
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
4.1
12.0
33
83
S01EE03
ATC
bimatoprost; ophthalmic
5.0
12.0
26
54
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
11.9
262
1746
A04AA01
ATC
ondansetron; systemic, rectal
2.6
11.7
70
285
D86
ICD-10 Finland
Sarcoidosis
66.0
11.6
13
*
H13.1*B02.3
ICD-10 Finland
Zoster conjunctivitis
+∞
11.5
11
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.2
11.5
46
150
H26.02
ICD-10 Finland
Presenil cataract
4.4
11.3
28
65
M01CB01
ATC
sodium aurothiomalate; parenteral
9.8
11.3
22
23
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
4.9
11.3
25
53
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
17.4
11.2
17
10
H15.1
ICD-10 Finland
Episcleritis
20.4
11.2
16
8
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.2
11.1
100
489
WX002
NOMESCO Finland
Sedation and analgesia
2.0
11.1
145
816
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.1
11.1
23
46
M01AX01
ATC
nabumetone; oral
3.2
11.0
44
143
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
12.2
10.9
19
16
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.8
10.8
24
51
H11.3
ICD-10 Finland
Conjunctival haemorrhage
3.3
10.7
41
130
N03AX12
ATC
[U] gabapentin; oral
2.0
10.7
129
705
N02BF02
ATC
pregabalin; oral
2.8
10.6
53
196
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
10.6
63
255
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.1
10.6
45
152
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
10.6
75
331
XCD10
NOMESCO Finland
Electrophysiological examination of eye
4.7
10.5
24
52
UJF30
NOMESCO Finland
Ileoscopy through colon
2.3
10.5
80
365
S01EX03, ,
ATC
5.5
10.4
20
37
H16.8
ICD-10 Finland
Other keratitis
111.6
10.4
11
*
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
+∞
10.4
10
*
H22.0*A69.2
ICD-10 Finland
Iridocyclitis in Lyme disease
+∞
10.4
10
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.6
10.4
34
97
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
10.3
308
2211
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
10.3
219
1432
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
10.3
156
921
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
23.8
10.3
14
6
N02BE01
ATC
paracetamol; systemic, rectal
2.1
10.1
634
5578
E0000UV, ,
ATC
1.7
10.0
297
2126
XX9XE
NOMESCO Finland
Other ultrasound examination
10.8
9.8
18
17
Z2446
NOMESCO Finland
Social worker
2.5
9.7
64
273
G53.0
ICD-10 Finland
Postzoster neuralgia
11.6
9.6
17
15
ZXA05
NOMESCO Finland
Left side
1.8
9.5
177
1110
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.3
9.4
76
355
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
+∞
9.4
9
*
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
9.4
9
*
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
8.2
9.4
20
25
D86.3
ICD-10 Finland
Sarcoidosis of skin
22.0
9.4
13
6
Z3231
NOMESCO Finland
Registered nurse
1.7
9.2
202
1327
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.0
9.2
26
67
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
9.2
36
116
NG1DA
NOMESCO Finland
X-ray of knees
4.5
9.1
22
50
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.6
9.1
54
219
G53.0*B02.20
ICD-10 Finland
Trigeminal neuralgia after shingles
15.8
9.1
14
9
J01DB01
ATC
cefalexin; oral
1.8
8.9
586
5077
M01AC06
ATC
meloxicam; systemic, rectal
1.6
8.9
259
1829
M01AB01
ATC
indometacin; systemic, rectal
2.5
8.9
58
246
L40.5
ICD-10 Finland
Arthropathic psoriasis
5.0
8.9
19
39
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.5
8.8
58
247
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
50.6
8.7
10
*
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
50.6
8.7
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
8.7
76
367
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.9
8.6
25
66
Z2221
NOMESCO Finland
Medical doctor
1.7
8.6
194
1282
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
16.5
8.6
13
8
R05
ICD-10 Finland
Cough
1.8
8.6
153
946
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.4
8.5
61
270
TNG10
NOMESCO Finland
Puncture of knee
6.5
8.5
21
33
ZXD05
NOMESCO Finland
Urgent procedure
1.7
8.5
216
1472
UJF92
NOMESCO Finland
Capsular endoscopy
4.4
8.4
21
49
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
91.1
8.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.4
260
1860
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
8.3
8
*
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
8.7
8.3
17
20
S01EC54
ATC
brinzolamide, combinations; ophthalmic
8.7
8.3
17
20
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.0
8.2
23
59
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.1
8.1
22
55
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
33.8
8.1
10
*
NAJ12
NOMESCO Finland
Posterior reduction of fracture of cervical spine
33.8
8.1
10
*
L04AA24
ATC
abatacept; parenteral
17.4
8.1
12
7
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
6.7
7.9
19
29
K50.1
ICD-10 Finland
Crohn disease of large intestine
6.7
7.9
19
29
H02AB04
ATC
methylprednisolone; systemic
1.9
7.9
104
583
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
7.9
7.9
17
22
K50.0
ICD-10 Finland
Crohn disease of small intestine
6.2
7.9
20
33
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.4
7.9
28
85
J01FA06
ATC
roxithromycin; oral
1.6
7.8
271
1985
H10.8
ICD-10 Finland
Other conjunctivitis
9.5
7.8
15
16
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.5
7.8
51
217
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.3
7.7
29
91
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
15.2
7.7
12
8
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
4.4
7.7
19
44
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
7.7
283
2099
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
7.7
66
316
H40.9
ICD-10 Finland
Glaucoma, unspecified
4.6
7.7
18
40
H01.0
ICD-10 Finland
Blepharitis
2.4
7.6
51
219
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.6
185
1240
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
7.6
75
379
RT160, ,
NOMESCO Finland
18.6
7.6
11
6
D07AC01
ATC
betamethasone; topical
1.6
7.6
246
1771
J31.0
ICD-10 Finland
Chronic rhinitis
2.2
7.5
66
319
CS494
NOMESCO Finland
Other visual field testing
3.7
7.5
23
63
RT272, ,
NOMESCO Finland
13.5
7.4
12
9
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
6.9
7.3
17
25
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
9.5
7.3
14
15
CGG31
NOMESCO Finland
Posterior corneal lamellar transplantation
+∞
7.3
7
*
H21.0
ICD-10 Finland
Hyphaema
+∞
7.3
7
*
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
7.3
7
*
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
+∞
7.3
7
*
CG2T4
NOMESCO Finland
Topography assessment of cornea
15.9
7.2
11
7
TAB00
NOMESCO Finland
Lumbar puncture
2.6
7.2
42
169
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.3
7.2
27
85
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
20.2
7.1
10
5
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
7.1
168
1116
J01MA12
ATC
levofloxacin; systemic
1.8
7.1
126
774
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.1
109
642
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
7.1
251
1840
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
3.9
7.0
20
52
J01FF01
ATC
clindamycin; systemic
1.6
6.9
185
1267
B00.10
ICD-10 Finland
Herpes simplex facialis
7.6
6.9
15
20
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.6
6.9
22
62
H35.9
ICD-10 Finland
Retinal disorder, unspecified
13.9
6.9
11
8
M13.0
ICD-10 Finland
Polyarthritis, unspecified
6.8
6.8
16
24
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.8
58
277
K07.60
ICD-10 Finland
Snapping jaw
2.4
6.7
45
194
M01AH02
ATC
rofecoxib; oral
1.9
6.6
91
517
A07EA06
ATC
budesonide; oral, local oral
2.8
6.6
33
123
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.0
6.6
69
358
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
6.6
40
165
M01CB03
ATC
auranofin; oral
10.1
6.5
12
12
R06AE07
ATC
cetirizine; oral
1.5
6.5
290
2223
SPAT1263
SPAT
Sampling
1.5
6.5
285
2179
ZXA00
NOMESCO Finland
Right side
1.6
6.5
185
1286
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
6.5
37
148
M01AE02
ATC
naproxen; oral, rectal
1.5
6.4
398
3259
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
70.5
6.4
7
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
6.4
300
2323
H25.8
ICD-10 Finland
Other senile cataract
2.0
6.4
70
369
CD2S4
NOMESCO Finland
Photography of eye
11.1
6.3
11
10
N06AX21
ATC
duloxetine; oral
1.9
6.3
80
444
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
+∞
6.3
6
*
H220, M084,
ICD-10 Finland
+∞
6.3
6
*
4AA17, ,
NOMESCO Finland
+∞
6.3
6
*
Z94.7
ICD-10 Finland
Corneal transplant status
+∞
6.3
6
*
H16.3
ICD-10 Finland
Interstitial and deep keratitis
+∞
6.3
6
*
H20.2
ICD-10 Finland
Lens-induced iridocyclitis
+∞
6.3
6
*
S01FB01
ATC
phenylephrine; ophthalmic
+∞
6.3
6
*
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
26.9
6.2
8
*
H16.2
ICD-10 Finland
Keratoconjunctivitis
26.9
6.2
8
*
M02AA07
ATC
piroxicam; topical
1.5
6.2
234
1728
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
5.1
6.2
18
36
A02BC03
ATC
lansoprazole; oral
1.6
6.2
194
1376
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
6.4
6.2
15
24
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
6.4
6.2
15
24
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
5.8
6.2
16
28
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
6.1
88
507
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.7
6.1
33
128
ZXC20
NOMESCO Finland
Use of chemical agents
3.8
6.1
18
48
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.2
6.1
16
39
L28
ICPC
Limited function/disability (L)
1.7
6.1
115
718
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.8
6.1
14
21
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
10.1
6.0
11
11
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.6
6.0
35
141
ZXD20
NOMESCO Finland
Day surgery
1.8
6.0
92
541
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
134
226
7.05
79.01
4.6
2.2
42.25
39.87
u/l
0.51
123
203
47
14
35.84
74.17
1.7
1.7
109.89
—
au/ml
—
9
0
504
2720
3.82
62.00
13.6
6.0
2.87
2.88
%
0.03
489
2566
571
3364
4.32
61.15
15.4
9.1
3.97
4.08
e9/l
0.68
536
2953
506
2763
3.77
60.54
13.2
5.9
56.73
56.97
%
0.18
491
2616
95
147
7.29
60.18
4.2
2.1
10.10
12.49
mg/l
1.66
90
136
509
2804
3.75
59.74
14.0
6.0
28.21
28.14
%
0.05
492
2657
94
182
5.79
47.42
1.7
1.6
0.01
0.10
iu/ml
0.92
16
37
616
4283
3.96
41.66
8.9
3.9
12.98
11.66
mm/h
1.44
583
3959
616
4436
3.63
36.00
12.3
7.5
82.27
79.18
u/l
0.42
589
4176
59
109
5.80
31.03
3.9
3.1
4.08
4.37
e9/l
0.44
59
109
41
52
8.30
30.52
1.2
1.3
—
—
—
0
0
59
112
5.65
30.14
4.1
3.5
57.10
58.09
%
0.23
59
112
445
2866
2.44
29.15
5.0
3.6
0.00
0.00
estimate
0.50
130
575
444
2864
2.43
28.88
6.3
4.9
0.01
0.00
estimate
0.34
125
543
447
2894
2.43
28.80
5.0
3.6
0.02
0.00
estimate
0.50
123
522
29
31
9.70
24.55
1.2
1.3
—
—
—
0
0
32
39
8.54
24.54
2.1
1.5
29.95
26.50
%
0.17
22
28
363
2332
2.12
21.45
2.9
2.3
73.81
75.96
nmol/l
0.75
332
2095
384
2559
2.07
20.13
6.6
6.2
1.22
1.21
mmol/l
1.05
350
2332
28
38
7.62
19.63
1.8
2.3
—
—
—
0
0
110
436
2.80
19.59
3.4
2.7
11.05
10.39
g/l
0.74
102
400
323
2045
2.05
19.23
4.2
3.7
49.03
112.94
e6/l
1.47
227
1452
404
2812
1.99
17.99
7.6
7.0
1.22
1.21
mmol/l
1.45
323
2407
681
5884
3.71
17.10
24.6
13.6
20.19
23.37
mg/l
2.05
609
4613
321
2100
1.95
16.76
3.9
3.2
—
—
—
0
0
497
3790
2.00
16.18
5.3
4.4
5.75
3561.98
e6/l
—
8
66
353
2408
1.91
16.04
5.0
5.0
35.35
35.77
g/l
0.70
326
2252
31
58
5.54
16.02
2.3
1.7
52.60
61.33
%
0.51
20
45
104
442
2.58
16.01
2.3
3.0
66.47
66.71
g/l
0.11
92
403
23
32
7.39
15.75
1.4
1.0
1.10
1.12
u/l
0.05
13
17
297
1925
1.92
15.67
3.0
3.4
2.35
2.35
mmol/l
0.03
266
1703
235
1421
1.97
15.14
2.8
2.2
3.38
3.04
mg/l
1.10
203
1218
50
144
3.66
15.11
1.7
1.4
—
—
—
0
0
24
16
15.47
14.96
2.9
5.5
6.47
9.62
mg/l
1.20
13
16
252
1570
1.93
14.80
6.1
3.9
0.00
0.01
estimate
0.69
122
525
413
3020
1.86
14.58
5.9
6.6
11.76
11.63
umol/l
0.04
391
2872
202
1210
1.93
13.08
2.6
2.6
4.73
5.62
e6/l
0.36
192
1093
610
5156
2.17
13.04
26.8
16.5
15.09
14.81
%
0.59
602
5079
33
79
4.33
12.83
1.1
1.1
—
—
—
0
0
695
6257
3.86
12.70
20.3
10.2
25.48
26.97
u/l
1.23
675
6045
134
708
2.10
12.29
3.7
2.5
137.40
131.20
ug/g
0.06
109
570
24
28
8.83
11.59
3.7
3.2
530.42
961.79
u/ml
1.42
24
28
241
1598
1.76
10.93
3.3
3.1
0.31
0.52
e6/l
1.22
196
1198
630
5506
2.12
10.56
20.5
12.5
83.17
82.60
ml/min/173m2
0.23
557
4515
83
385
2.31
10.45
2.9
2.4
19.64
15.64
au/ml
—
7
25
42
138
3.17
10.36
1.9
1.7
17784.27
16953.64
e6/l
0.03
33
105
258
1765
1.72
10.36
3.5
3.2
150.64
94.32
e6/l
0.18
211
1353
313
2256
1.68
10.34
5.5
3.7
—
—
—
0
0
189
1187
1.80
10.21
1.7
1.5
2.68
2.39
g/l
0.71
122
725
117
629
2.03
10.13
2.7
2.9
1.93
1.77
%
0.89
98
581
42
140
3.12
10.12
2.5
1.7
—
—
—
0
0
48
174
2.88
10.00
2.6
3.0
—
—
—
0
0
104
542
2.07
9.79
2.3
2.0
349.22
374.99
nmol/l
0.60
98
504
114
616
2.01
9.72
3.7
4.4
234.23
255.47
u/l
0.84
105
582
57
232
2.58
9.53
1.5
2.1
1.37
1.48
g/l
0.38
46
204
302
2195
1.65
9.42
4.1
3.5
28.21
37.71
ng/l
0.94
203
1497
130
744
1.91
9.36
6.0
6.2
1.02
1.05
mmol/l
0.53
124
683
74
348
2.25
9.01
1.3
1.2
159.45
157.62
u/ml
0.01
67
322
161
999
1.79
8.93
1.9
1.7
1309.14
1180.46
nmol/l
0.94
117
748
82
412
2.12
8.47
4.4
4.3
92.62
81.53
ng/l
0.57
73
369
106
587
1.94
8.38
4.1
3.1
—
—
—
0
0
143
877
1.79
8.19
1.8
1.9
—
—
—
0
0
45
179
2.61
7.90
1.7
1.8
—
—
—
0
0
238
1689
1.61
7.85
2.2
2.1
180.41
288.87
u/l
1.00
219
1601
338
2604
1.56
7.82
18.9
13.2
1.27
1.24
inr
0.20
114
777
704
6603
3.52
7.67
34.6
20.0
39.78
40.37
%
1.85
672
6199
704
6604
3.51
7.65
34.8
19.9
258.26
250.04
e9/l
2.64
691
6439
704
6608
3.49
7.56
34.8
19.9
4.43
4.52
e12/l
5.22
690
6424
704
6611
3.47
7.49
34.9
20.0
133.29
135.92
g/l
5.18
698
6522
418
3401
1.54
7.40
4.9
4.8
6.57
6.68
mmol/l
0.53
399
3180
134
830
1.75
7.37
2.8
2.3
2.32
2.36
g/l
0.34
122
777
18
42
4.37
7.25
1.2
1.0
—
—
—
0
0
141
894
1.72
7.13
2.9
2.4
12.58
13.21
umol/l
0.43
128
834
262
1943
1.55
6.98
3.7
3.5
29.49
33.58
u/l
1.85
239
1853
658
6025
2.02
6.98
21.3
15.7
139.36
139.67
mmol/l
2.59
649
5867
658
6043
1.99
6.64
21.6
15.8
3.94
3.97
mmol/l
2.40
648
5878
12
12
10.15
6.55
1.1
1.8
—
—
—
0
0
30
107
2.88
6.49
1.4
1.6
—
—
—
0
0
203
1445
1.56
6.40
2.5
2.8
6490.49
8234.38
umol/l
0.19
179
1275
34
133
2.63
6.20
1.3
1.6
—
—
—
0
0
80
446
1.89
6.18
3.4
3.7
1.23
1.23
mmol/l
0.63
68
388
170
1173
1.59
6.10
2.0
1.7
447.02
10907661.99
pmol/l
0.77
140
981
317
2513
1.47
5.85
3.8
2.8
124.08
124.08
ug/l
0.00
295
2327
100
611
1.74
5.73
1.8
1.9
—
—
—
0
0
44
202
2.25
5.72
1.8
2.3
4.50
3.58
g/l
0.64
38
188
44
202
2.25
5.72
1.8
2.3
7.44
7.42
g/l
0.03
38
188
44
202
2.25
5.72
1.8
2.3
—
—
—
0
0
42
189
2.30
5.72
1.8
2.3
3.04
3.00
g/l
0.09
36
175
121
781
1.66
5.66
3.0
2.4
22.82
22.67
%
0.04
105
678
185
1324
1.53
5.60
1.7
1.5
21.98
20.70
nmol/l
0.49
156
1125
32
129
2.55
5.52
1.7
1.4
—
—
—
0
0
98
606
1.71
5.37
1.8
1.9
—
—
—
0
0
39
175
2.30
5.36
1.9
2.5
2.43
1.12
g/l
0.58
33
160
19
58
3.34
5.33
1.2
1.1
—
—
—
0
0
33
138
2.46
5.29
1.5
1.6
6.88
8.89
e6/l
0.15
24
107
33
138
2.46
5.29
1.6
1.7
2005.79
972.95
e6/l
0.22
24
110
213
1590
1.48
5.22
3.3
3.1
1538.55
1253.76
ng/l
0.50
181
1348
148
1028
1.55
5.09
2.9
3.0
2.46
2.45
mmol/l
0.41
129
909
143
987
1.56
5.05
1.3
1.3
32.15
35.60
iu/ml
0.07
31
316
284
2254
1.43
5.00
2.1
1.9
95.91
96.41
pmol/l
0.05
158
1182
20
66
3.09
4.98
1.2
1.1
—
—
—
0
0
70
403
1.82
4.91
2.0
1.6
—
—
—
0
0
57
308
1.92
4.86
1.8
1.7
—
—
—
0
0
237
1830
1.44
4.81
2.6
2.6
53.65
58.31
u/l
1.65
221
1712
39
184
2.18
4.78
1.9
2.3
9.87
10.35
g/l
0.28
33
169
20
68
3.00
4.74
1.2
1.1
—
—
—
0
0
140
977
1.54
4.69
2.9
2.8
0.78
0.99
e6/l
0.70
85
555
16
49
3.32
4.49
2.8
2.8
41.00
40.20
%
0.05
11
28
129
893
1.54
4.48
2.6
3.7
0.81
0.81
mmol/l
0.05
118
842
11
20
5.57
4.30
1.1
1.1
1396.91
1800.10
miu/ml
0.52
11
20
25
102
2.50
4.26
2.5
2.3
16.24
16.18
%
0.02
13
52
19
68
2.84
4.15
2.7
1.9
31.32
33.41
pg
1.12
19
68
23
93
2.52
4.00
1.3
1.8
—
—
—
0
0
33
160
2.11
3.82
1.7
4.0
34.33
32.47
mg/l
0.09
24
134
33
160
2.11
3.82
1.8
4.0
45.78
96.78
mg/l
0.69
23
132
225
1793
1.37
3.63
3.1
3.2
7.67
7.71
mmol/l
0.04
190
1521
168
1276
1.41
3.61
1.7
1.8
1.28
1.17
mg/l
0.22
126
966
33
164
2.06
3.60
1.9
2.3
38.28
37.66
g/l
0.28
27
150
19
74
2.61
3.57
1.1
1.1
—
—
—
0
0
19
75
2.57
3.49
1.6
1.6
—
—
—
0
0
582
5384
1.42
3.38
4.5
4.6
1.89
2.14
mu/l
0.56
533
4934
36
190
1.94
3.35
1.2
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
176
1.98
3.34
2.9
2.8
0.32
0.36
u/ml
0.26
19
94
55
332
1.71
3.34
2.0
1.5
—
—
—
0
0
321
2734
1.31
3.22
2.6
2.6
—
—
—
0
0
203
1625
1.35
3.12
3.2
3.3
711.85
261.20
mg/l
0.47
129
1045
31
160
1.98
3.09
1.1
1.2
—
1.31
—
0
8
169
1317
1.37
3.08
5.9
3.9
1.02
1.02
kg/l
0.22
16
178
119
877
1.43
3.01
1.8
2.3
29.78
29.73
s
0.02
114
852
14
51
2.78
3.00
1.3
1.7
—
—
—
0
0
18
75
2.44
2.99
1.6
1.6
—
—
—
0
0
59
376
1.62
2.94
3.1
4.2
1.55
1.76
mmol/l
0.14
41
278
15
58
2.62
2.89
1.4
1.9
—
—
—
0
0
26
132
2.01
2.73
1.2
1.5
112.78
110.88
u/ml
—
9
24
7
14
5.04
2.73
1.0
1.0
—
—
—
0
0
210
1723
1.31
2.67
4.0
3.9
11.15
9.30
mg/mmol
0.15
136
1093
8
20
4.03
2.57
1.3
1.3
—
—
—
0
0
18
81
2.25
2.55
1.1
1.2
—
—
—
0
0
488
4467
1.28
2.54
3.7
3.9
15.04
14.73
pmol/l
1.60
446
4063
14
56
2.53
2.54
3.1
2.1
—
—
—
0
0
16
69
2.35
2.50
1.4
1.8
—
—
—
0
0
11
37
3.00
2.49
1.2
1.1
—
—
—
0
0
169
1363
1.31
2.42
1.3
1.3
1.78
1.41
u/ml
0.12
52
378
9
27
3.36
2.40
4.9
2.4
21.87
349.78
ug/l
—
9
21
92
678
1.41
2.34
2.7
3.3
13.23
8.31
umol/l
0.56
75
597
170
1382
1.30
2.29
2.5
2.3
—
—
—
0
0
20
99
2.05
2.28
1.6
1.6
—
—
—
0
0
568
5332
1.30
2.26
6.1
5.6
39.43
39.70
mmol/mol
0.26
523
4969
18
86
2.12
2.24
1.6
1.5
—
—
—
0
0
31
180
1.75
2.22
1.9
1.5
1.15
1.19
g/l
0.32
31
169
5
9
5.58
2.21
1.4
1.2
—
—
—
0
0
13
54
2.43
2.21
1.1
1.2
—
—
—
0
0
13
54
2.43
2.21
1.1
1.2
—
—
—
0
0
13
54
2.43
2.21
1.1
1.2
—
—
—
0
0
119
929
1.34
2.13
3.4
2.9
1.92
2.38
e6/l
0.39
65
508
22
116
1.92
2.13
1.0
1.2
—
1.18
—
0
9
85
630
1.40
2.11
5.6
7.8
1.26
1.21
mmol/l
0.04
67
502
10
37
2.73
2.07
1.3
1.2
1.99
1.87
mmol/l
—
10
37
24
132
1.85
2.06
1.4
1.7
—
—
—
0
0
90
677
1.38
2.05
8.8
7.1
—
—
—
0
0
8
26
3.10
2.02
1.5
1.3
—
—
—
0
0
28
163
1.75
2.01
1.1
1.3
—
—
—
0
0
174
1445
1.27
1.97
4.5
4.0
88.96
91.51
%
0.63
162
1415
19
98
1.96
1.96
1.1
1.1
—
—
—
0
0
423
3867
1.23
1.96
3.2
3.1
—
—
—
0
0
595
5651
1.30
1.95
4.4
4.4
5.95
5.92
mmol/l
0.21
534
5166
36
552
0.63
1.94
1.9
1.6
—
—
—
0
0
8
27
2.98
1.94
1.6
1.7
—
—
—
0
0
6
16
3.77
1.94
1.7
1.1
96.33
97.31
%
—
6
16
9
33
2.75
1.93
1.6
1.6
—
—
—
0
0
75
554
1.39
1.91
2.8
2.5
34.62
33.71
u/l
0.06
60
477
121
964
1.31
1.89
1.3
1.2
14.61
11.73
u/ml
0.14
42
361
50
343
1.49
1.88
2.7
3.5
4.49
4.65
pmol/l
0.28
41
304
8
28
2.88
1.86
1.6
1.7
—
—
—
0
0
8
28
2.88
1.86
1.1
1.0
—
—
—
0
0
6
17
3.55
1.84
1.0
1.9
—
—
—
0
0
136
1106
1.28
1.82
1.6
1.6
—
—
—
0
0
12
53
2.29
1.81
1.1
1.2
—
—
—
0
0
12
53
2.29
1.81
1.1
1.2
—
—
—
0
0
9
35
2.59
1.80
1.1
1.3
—
28.33
—
0
6
13
60
2.19
1.78
1.3
1.8
—
—
—
0
0
73
544
1.38
1.78
2.1
2.4
0.21
0.22
g/l
0.09
68
512
613
5865
1.30
1.75
4.9
4.8
2.67
2.76
mmol/l
1.68
561
5423
9
36
2.52
1.74
1.1
1.1
—
—
—
0
0
9
36
2.52
1.74
1.4
1.2
—
—
—
0
0
83
634
1.35
1.74
5.7
7.6
12.00
12.35
kpa
0.29
78
609
8
30
2.68
1.72
1.1
1.7
—
—
—
0
0
8
30
2.68
1.72
1.1
1.7
—
—
—
0
0
29
179
1.65
1.72
2.3
1.6
—
—
—
0
0
5
13
3.86
1.71
1.2
2.0
1.16
2.54
ug/l
—
5
5
5
14
3.59
1.62
1.2
1.4
—
—
—
0
0
61
449
1.39
1.61
2.6
2.5
66.77
67.51
ml/min/173m2
0.05
31
195
23
136
1.71
1.60
1.4
1.7
—
—
—
0
0
8
32
2.52
1.60
1.1
1.5
—
—
—
0
0
24
144
1.69
1.59
1.4
1.3
—
—
—
0
0
10
43
2.34
1.59
1.1
1.2
—
81.83
—
0
6
15
79
1.92
1.50
1.5
1.6
—
—
—
0
0
423
3924
1.19
1.49
3.4
3.2
48.75
48.16
u/l
0.05
385
3683
69
527
1.34
1.47
6.5
8.3
121.30
121.04
g/l
0.04
69
512
10
45
2.24
1.47
1.3
1.2
—
—
—
0
0
11
52
2.13
1.45
1.9
1.3
1226.67
1806.91
e6/l
—
6
35
209
1827
1.20
1.44
4.7
4.7
2.97
2.43
ug/l
0.28
186
1650
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
40
2.27
1.40
1.1
1.2
—
—
—
0
0
9
40
2.27
1.40
1.4
1.6
—
—
—
0
0
128
1069
1.24
1.38
4.4
3.7
554.39
388.51
ng/l
0.19
105
821
14
75
1.88
1.35
1.0
1.0
—
—
—
0
0
32
218
1.49
1.30
1.7
1.8
—
—
—
0
0
37
262
1.43
1.25
3.2
4.8
24.79
24.93
mmol/l
0.09
30
248
30
204
1.49
1.24
1.6
1.7
—
—
—
0
0
16
93
1.74
1.22
1.1
1.1
—
—
—
0
0
25
164
1.54
1.22
1.2
1.1
—
—
—
0
0
5
19
2.64
1.22
2.0
3.6
—
—
—
0
0
5
19
2.64
1.22
2.0
3.6
—
—
—
0
0
5
19
2.64
1.22
1.0
1.0
—
—
—
0
0
5
19
2.64
1.22
3.2
5.7
—
—
—
0
0
596
5742
1.22
1.21
4.5
4.3
1.49
1.46
mmol/l
0.93
541
5317
8
37
2.17
1.21
1.3
1.4
4.58
8.90
u/l
—
8
30
24
156
1.56
1.21
1.2
1.3
—
—
—
0
0
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
23
150
1.55
1.15
1.2
1.3
208.41
236.05
u/ml
—
9
87
13
72
1.82
1.15
1.2
2.8
9.10
8.95
umol/l
—
6
50
5
20
2.51
1.15
1.2
1.1
—
93.36
—
0
11
127
1083
1.21
1.14
3.2
2.9
0.70
0.77
ug/l
0.47
91
680
598
5774
1.21
1.13
4.5
4.3
4.59
4.66
mmol/l
0.97
545
5368
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
10
52
1.94
1.06
1.1
1.2
—
—
—
0
0
175
1546
1.17
1.06
1.7
1.7
1.35
1.38
mmol/l
0.20
138
1306
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
10
53
1.90
1.01
1.3
1.4
—
—
—
0
0
5
23
2.18
0.98
1.4
1.8
—
—
—
0
0
5
23
2.18
0.98
1.4
1.8
—
—
—
0
0
5
23
2.18
0.98
1.4
2.1
25.00
26.96
umol/l
—
5
23
5
23
2.18
0.98
1.4
1.8
—
—
—
0
0
24
165
1.47
0.98
1.7
1.6
—
—
—
0
0
0
30
0.00
0.97
0.0
2.3
—
51.73
—
0
22
9
50
1.81
0.97
1.4
2.4
—
—
—
0
0
574
5545
1.17
0.96
3.9
3.9
1.28
1.29
mmol/l
0.15
517
5108
13
77
1.70
0.95
1.5
1.3
—
—
—
0
0
9
52
1.74
0.92
1.0
1.0
—
—
—
0
0
9
52
1.74
0.92
1.1
1.1
1.53
1.44
nmol/l
—
9
47
32
240
1.35
0.84
1.3
1.5
—
—
—
0
0
81
687
1.20
0.80
4.8
4.4
34.29
31.45
%
1.26
55
456
9
53
1.71
0.75
1.7
1.6
—
—
—
0
0
9
53
1.71
0.75
1.7
1.6
—
—
—
0
0
9
53
1.71
0.75
1.7
1.6
—
—
—
0
0
27
201
1.36
0.75
3.0
2.1
2038.09
4287.11
u/l
0.44
14
81
5
25
2.01
0.73
1.2
1.2
70.20
11.84
u/l
—
5
19
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
13
84
1.56
0.72
1.3
1.5
—
—
—
0
0
9
57
1.59
0.71
3.1
4.2
—
—
—
0
0
5
27
1.86
0.68
1.2
1.1
106.60
72.76
u/l
—
5
21
20
145
1.39
0.66
1.5
1.4
—
—
—
0
0
58
488
1.20
0.65
1.9
2.4
4.30
7.52
ug/l
1.84
45
439
5
29
1.73
0.64
1.2
1.1
157.60
185.09
iu/ml
—
5
29
14
96
1.47
0.62
1.4
1.7
—
—
—
0
0
14
96
1.47
0.62
1.4
1.7
—
—
—
0
0
8
51
1.57
0.60
1.3
1.1
81.13
48.66
u/l
—
8
45
34
420
0.80
0.59
1.2
1.2
36.88
149.43
iu/ml
—
8
170
10
65
1.55
0.55
6.3
3.4
2.91
6.07
nmol/l
—
10
65
6
37
1.63
0.55
1.2
1.3
—
—
—
0
0
6
37
1.63
0.55
1.2
1.3
—
—
—
0
0
6
37
1.63
0.55
1.8
1.2
—
—
—
0
0
66
573
1.17
0.54
3.6
4.4
4.12
32.80
ug/l
1.29
53
477
6
39
1.54
0.53
1.3
1.6
—
—
—
0
0
22
170
1.30
0.52
1.1
1.3
—
—
—
0
0
51
436
1.18
0.51
3.2
3.0
154.04
198.98
ng/l
0.68
45
397
160
1480
1.10
0.50
4.8
4.1
21.30
21.13
%
0.05
83
671
12
84
1.44
0.49
1.6
1.4
—
—
—
0
0
12
84
1.44
0.49
1.6
1.4
—
—
—
0
0
19
145
1.32
0.49
1.2
1.5
—
—
—
0
0
19
145
1.32
0.49
1.4
1.9
2.00
6.50
iu/l
—
6
50
29
235
1.24
0.49
3.8
1.8
2.43
3.61
mg/l
0.66
24
174
37
309
1.21
0.48
6.4
4.9
23.84
24.00
mmol/l
0.15
37
304
12
85
1.42
0.47
1.6
1.4
—
—
—
0
0
12
85
1.42
0.47
1.6
1.4
—
—
—
0
0
12
85
1.42
0.47
1.6
1.4
—
—
—
0
0
12
85
1.42
0.47
1.6
1.4
—
—
—
0
0
14
103
1.37
0.45
1.5
1.7
—
—
—
0
0
14
103
1.37
0.45
1.1
1.1
0.36
4.04
u/ml
—
7
60
22
175
1.27
0.43
2.1
3.6
4.11
3.58
g/l
0.86
22
168
5
31
1.62
0.43
1.4
1.7
—
—
—
0
0
5
31
1.62
0.43
1.4
1.7
—
—
—
0
0
22
176
1.26
0.42
1.8
1.4
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
22
178
1.24
0.39
1.4
1.1
—
—
—
0
0
9
66
1.37
0.38
1.4
1.7
—
—
—
0
0
9
66
1.37
0.38
1.4
1.7
—
—
—
0
0
68
755
0.89
0.38
1.6
1.8
1.44
1.47
%
0.13
54
666
9
67
1.35
0.38
1.4
1.7
14.24
16.29
ug/l
—
9
67
22
179
1.24
0.37
1.4
1.1
—
—
—
0
0
9
69
1.31
0.37
1.3
1.3
2.16
2.97
ug/l
—
9
59
9
69
1.31
0.37
1.4
1.3
0.56
0.59
nmol/l
—
9
63
5
37
1.35
0.37
1.2
1.8
—
—
—
0
0
71
641
1.12
0.37
2.0
2.0
—
—
—
0
0
6
44
1.37
0.34
1.2
1.4
76.17
75.70
umol/l
—
6
44
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
6
44
1.37
0.34
1.3
1.2
—
—
—
0
0
32
370
0.86
0.33
2.5
2.0
—
—
—
0
0
7
53
1.32
0.31
1.0
1.2
—
—
—
0
0
7
53
1.32
0.31
1.7
1.3
—
—
—
0
0
8
63
1.27
0.28
2.8
2.3
—
—
—
0
0
19
159
1.20
0.27
1.5
1.4
236.25
287.13
ug/g
—
8
92
17
203
0.83
0.26
1.7
1.7
—
—
—
0
0
6
84
0.71
0.24
2.7
2.5
108.50
104.92
mmol/l
—
6
84
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
2.2
—
36.50
—
0
10
42
460
0.91
0.21
2.4
2.2
11.70
13.59
nmol/l
0.91
37
420
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
5
43
1.16
0.21
1.4
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
11
91
1.21
0.17
1.5
1.2
4.80
5.26
u/ml
—
5
27
14
163
0.86
0.17
1.3
1.5
—
—
—
0
0
13
110
1.19
0.17
1.2
1.0
—
11.03
—
0
9
10
82
1.22
0.17
1.2
1.4
20.25
24.12
u/l
—
10
69
13
111
1.17
0.16
1.5
1.4
—
—
—
0
0
13
111
1.17
0.16
1.5
1.4
—
—
—
0
0
61
575
1.07
0.16
4.9
4.4
1.67
1.80
mmol/l
0.13
49
472
16
140
1.15
0.15
2.6
2.3
13.83
76.57
ug/min
—
6
87
11
129
0.85
0.15
3.9
6.5
102.27
105.02
mmol/l
0.89
11
114
27
293
0.92
0.12
2.6
1.9
—
—
—
0
0
16
179
0.89
0.12
2.0
1.7
35.37
40.72
nmol/l
0.65
16
172
15
133
1.13
0.12
1.2
1.4
—
—
—
0
0
15
133
1.13
0.12
1.2
1.4
—
—
—
0
0
15
133
1.13
0.12
1.2
1.4
—
—
—
0
0
15
133
1.13
0.12
1.2
1.4
—
—
—
0
0
13
114
1.14
0.12
1.3
1.6
—
—
—
0
0
22
240
0.91
0.11
2.9
4.8
1.45
1.56
%
0.37
22
223
11
125
0.88
0.10
1.5
1.8
211.82
229.86
pmol/l
0.48
11
117
30
318
0.94
0.08
1.1
1.0
—
—
—
0
0
7
66
1.06
0.08
1.9
2.2
13.29
12.97
%
—
7
66
7
81
0.86
0.07
1.1
1.4
—
—
—
0
0
31
295
1.05
0.06
4.3
3.4
0.66
0.66
%
0.03
31
295
16
172
0.93
0.06
1.5
1.3
107.40
251.03
miu/ml
—
5
81
10
90
1.11
0.05
1.1
1.3
—
—
—
0
0
88
862
1.02
0.05
1.6
1.5
—
—
—
0
0
30
313
0.96
0.05
1.6
1.3
—
—
—
0
0
10
110
0.91
0.05
1.7
1.6
—
—
—
0
0
10
91
1.10
0.04
1.1
1.1
—
—
—
0
0
14
149
0.94
0.03
1.8
1.7
—
—
—
0
0
31
304
1.02
0.00
4.3
3.4
1.21
1.25
%
0.10
31
304
71
708
1.00
0.00
2.3
2.2
—
—
—
0
0
9
89
1.01
-0.00
1.1
1.1
1.57
1.53
g/l
—
9
81
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
0.56
—
0
9
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
79
0.88
-0.00
1.3
1.3
8.38
7.29
mmol/l
—
7
67
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
65.67
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
12.37
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint H7_IRIDOCYCLITISINOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_IRIDOCYCLITISINOTH | 1.095 [0.91, 1.31] | 0.326 |
| Birth year | 0.994 [0.99, 1.0] | 0.156 |
During the follow-up period (1.1.1998 — 31.12.2019), 252 out of 1718 females with H7_IRIDOCYCLITISINOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_IRIDOCYCLITISINOTH | 1.374 [1.14, 1.66] | 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1621 males with H7_IRIDOCYCLITISINOTH died.
Mortality risk
Mortality risk for people of age
years, who have H7_IRIDOCYCLITISINOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.099% | 0.265% |
| 5 | 0.543% | 1.506% |
| 10 | 1.49% | 3.577% |
| 15 | 2.793% | 6.832% |
| 20 | 5.292% | 11.356% |
Relationships between endpoints
↥Index endpoint: H7_IRIDOCYCLITISINOTH – Iridocyclitis in diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data